Literature DB >> 8047688

Aggressive oligodendroglioma: a chemosensitive tumor.

J G Cairncross1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8047688     DOI: 10.1007/978-3-642-85039-4_13

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


× No keyword cloud information.
  5 in total

1.  Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors.

Authors:  Judith Jeuken; Sandra Cornelissen; Sandra Boots-Sprenger; Sabine Gijsen; Pieter Wesseling
Journal:  J Mol Diagn       Date:  2006-09       Impact factor: 5.568

2.  Postoperative radiotherapy and chemotherapy in the management of oligodendroglioma: single institutional review of 88 patients.

Authors:  Gokhan Ozyigit; Cem Onal; Murat Gurkaynak; Figen Soylemezoglu; Faruk Zorlu
Journal:  J Neurooncol       Date:  2005-11       Impact factor: 4.130

3.  Temozolomide treatment for newly diagnosed anaplastic oligodendrogliomas: a clinical efficacy trial.

Authors:  A Taliansky-Aronov; F Bokstein; I Lavon; T Siegal
Journal:  J Neurooncol       Date:  2006-07-20       Impact factor: 4.130

4.  Role of exclusive chemotherapy as first line treatment in oligodendroglioma.

Authors:  Marie Pierre Sunyach; Anne Jouvet; David Perol; Emmanuel Jouanneau; Jacques Guyotat; Laurence Gignoux; Christian Carrie; Didier Frappaz
Journal:  J Neurooncol       Date:  2007-06-14       Impact factor: 4.130

5.  On the pathway to success: defining subtypes of gliomas for better treatment selection and refining the meaning of success.

Authors:  Mark R Gilbert
Journal:  Curr Oncol Rep       Date:  2013-02       Impact factor: 5.075

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.